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Autoimmunity as a Consequence of
Retrovirus-Mediated Expression
of C-FLIP in Lymphocytes
that generally resembles the disease seen in Fas-defi-
cient mice (Fisher et al., 1995; Rieux-Laucat et al., 1995).
Fas-mediated apoptosis has also been implicated as a
mechanism responsible for the tissue destruction asso-
ciated with autoimmune diseases (Chervonsky et al.,
Luk Van Parijs,* Yosef Refaeli,²
Abul K. Abbas², and David Baltimore*³
*Department of Biology
California Institute of Technology
Pasadena, California 91125
²Division of Immunology 1997; Itoh et al., 1997; Sabelko et al., 1997; Waldner et
al., 1997) and is involved in the elimination of virus-Department of Pathology
Harvard Medical School infected cells and tumor cells (Shresta et al., 1998).
A novel class of molecules has been described thatand Brigham and Women's Hospital
Boston, Massachusetts 02115 can inhibit signaling by death receptors of the TNFR
family. They are termed FLICE-inhibitory proteins (FLIPs)
because they block the recruitment and activation of
procaspase 8 (FLICE) (Thome et al., 1997). flip genesSummary
were initially identified in the genomes of a number of
viruses, including some that are lymphotropic (ThomeThe induction of apoptosis by death receptors serves
to regulate immune responses by eliminating un- et al., 1997). It has been proposed that v-FLIPs function
to promote viral persistence and dissemination bywanted and harmful cells. Mature lymphocytes ex-
press FLICE inhibitory proteins (FLIPs) that block blocking death receptor±mediated elimination of in-
fected cells. Furthermore, many of the viruses that ex-death receptor±induced cell death. Here, we show that
both B and T cells downregulate c-FLIP upon activa- press v-FLIPs are tumorigenic, suggesting that these
molecules may also play a role in oncogenesis (Tschopption in vitro. Retrovirus-mediated expression of c-FLIP
blocks Fas-induced apoptosis of activated lympho- et al., 1998).
A cellular homolog of the v-FLIPs, called c-FLIP, existscytes but does not affect cell death resulting from
cytokine withdrawal. In vivo, c-FLIP expression results in humans and mice (Irmler et al., 1997). It has at least
two splice variants, FLIPS and FLIPL, both of whichin defective superantigen-mediated elimination of T
cells, the accumulation of activated B cells, the pro- can inhibit death receptor±induced apoptosis. Many cell
types, including naive lymphocytes, express high levelsduction of autoantibodies, and the development of au-
toimmune disease. No effect was seen on negative of c-FLIP. Significantly, T cells downregulate this mole-
cule when they are activated in vitro (Figure 1; Irmler etselection of thyomocytes. These results suggest that
activation-dependent downregulation of c-FLIP ren- al., 1997; Refaeli et al., 1998). Since activated lympho-
cytes are also more sensitive to Fas-mediated apoptosisders mature lymphocytes sensitive to death receptor±
mediated apoptosis and is required to maintain self- than naive cells, c-FLIP may function to regulate this
pathway of programmed cell death. This would placetolerance.
c-FLIP in a position to control the elimination of autore-
active lymphocytes and to play a role in the maintenanceIntroduction
of self-tolerance. To test this idea, we have examined
the expression of c-FLIP in B and T cells following activa-The immune system has developed a number of mecha-
tion and have used a retrovirus-based gene transfernisms to eliminate cells that are harmful to the body,
system to constitutively express c-FLIP in lymphocytes.including lymphocytes that respond to self-antigens and
cells that are infected with viruses or other intracellular
pathogens. The best understood of these involves the Results and Discussion
death receptor, Fas, a member of the tumor necrosis
factor (TNF) receptor superfamily (Nagata, 1997). Similar c-FLIP Is Downregulated following
Lymphocyte Activationto other members of this protein family, engagement of
Fas by its ligand, FasL, results in the recruitment of the Recently, a number of studies have suggested that the
level of c-FLIP in T cells determines their sensitivity toaspartate-specific cysteine protease precursor, procas-
pase 8, leading to the activation of a caspase cascade death receptor±mediated apoptosis (Irmler et al, 1997;
Refaeli et al., 1998). We therefore wanted to examineand the induction of apoptosis (Boldin et al., 1996; Muzio
et al., 1996). The physiological importance of this death the levels of c-FLIP in B and T lymphocytes both before
and after activation. Naive T cells express high levelsreceptor is illustrated by the phenotype of mice that
lack a functional fas gene. These mice develop systemic of c-FLIP but lose expression of the protein and its
mRNA and become sensitive to Fas-mediated apoptosisautoimmunity characterized by an accumulation of lym-
phocytes and the production of multiple autoantibodies when they are activated with their cognate peptide or
anti-CD3 (Figure 1; data not shown; Irmler et al., 1997;(Adachi et al., 1995; Nagata and Suda, 1995). Notably,
Fas deficiencies in humans have recently been associ- Refaeli et al., 1998). Similarly, naive B cells become
sensitive to Fas-mediated apoptosis and lose c-FLIPated with an autoimmune lymphoproliferative syndrome
expression after they are activated with anti-CD40 (Fig-
ure 1; data not shown). Thus, in vitro activation of lym-³ To whom correspondence should be addressed (e-mail: baltimo@
cco.caltech.edu). phocytes results in a reduction of c-FLIP levels and
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Figure 1. c-FLIP Expression and Inhibition of Fas-Mediated Apoptosis in Activated Lymphocytes
(A) Purified T or B cells were activated with antibodies to anti-CD3 and anti-CD28 (T cells) or anti-CD40 (B cells) and infected with a c-FLIP-
expressing (FLIP) or control (GFP) retrovirus or left untreated (no virus). Infected cells showed green fluoresence when analyzed by flow
cytometry.
(B) The levels of c-FLIP protein expressed by naive (naive) or activated T and B cells that had been infected with a c-FLIP-expressing (FLIP)
or control (GFP) retrovirus, or not infected (no), were determined by Western blot analysis using an antibody to the N terminus of FLIP (FLIP)
or the flag epitope present at the N terminus of the retrovirus-encoded c-FLIP molecule (Flag).
(C) Infected T and B cells were cultured for 20 hr on plates coated with anti-Fas antibody to induce Fas-mediated cell death (middle panels)
or anti-CD3 antibody (T cells only) to induce AICD (left panel). Infected B cells were cultured with activated DO.11 T cells, in the presence of
increasing concentrations of OVA peptide, to induce B cell killing (right panel).
increased sensitivity to death receptor±mediated apo- Expression of c-FLIP also interfered with activation-
induced cell death (AICD) of T cells (Figure 1), a form ofptosis.
apoptosis that occurs when T cells coexpress Fas and
Fas ligand following exposure to high doses of antigenRetrovirus-Mediated Expression of c-FLIP
or antibodies to anti-CD3 (Brunner et al., 1995; Dhein etin Activated Lymphocytes Blocks Death
al., 1995; Ju et al., 1995). Furthermore, activated B cellsReceptor±Mediated Apoptosis
expressing this antiapoptotic molecule were protectedWe next wanted to study the effects of constitutive
from T cell±mediated killing (Figure 1). This form of apo-c-FLIP expression in B and T lymphocytes. Enforced ex-
ptosis is induced when activated B cells present antigenpression of c-FLIP has been shown to block Fas-medi-
to T cells. It requires Fas and is thought to serve toated apoptosis of B and T cell lines as well as of activated
eliminate autoreactive B cells (Rathmell et al., 1995;primary T cells (Kataoka et al., 1998; Refaeli et al., 1998).
Rothstein et al., 1995; L. V. P. and D. B., unpublishedHere, we used a retrovirus to express c-FLIP in primary
data). In contrast, c-FLIP did not block cell death ofB and T lymphocytes. The cDNA for flag-tagged c-FLIP
activated lymphocytes cultured in the absence of cyto-was introduced into the retroviral vector, pMIG (Van
kines or mitogenic stimuli (data not shown). These re-Parijs et al., 1999). This vector expresses a bicistronic
sults show that c-FLIP is a specific inhibitor of deathmRNA encoding both the test protein and, as a marker
receptor±mediated apoptosis but not other forms of cellof infection, the green fluorescent protein (GFP). High-
death in primary lymphocytes.titer retrovirus stocks were generated by transient trans-
fection of the Bosc 23 packaging cell line (Pear et al.,
1993) and were used to infect in vitro activated B and Retrovirus-Mediated Expression of c-FLIP Does
Not Affect Lymphocyte DevelopmentT cells (Figure 1). This resulted in levels of c-FLIP expres-
sion in activated lymphocytes that were comparable to To examine the in vivo consequences of retroviral ex-
pression of c-FLIP in lymphocytes, lethally irradiatedthose found in naive cells (Figure 1; data not shown).
Retrovirus-mediated expression of c-FLIP in activated mice were reconstituted with bone marrow cells that
had been infected in vitro with a c-FLIP-expressing ret-B and T cells blocked the induction of apoptosis by Fas
(Figure 1). This finding indicates that Fas stimulates a rovirus (FLIP mice) or a control retrovirus (GFP mice).
After 8 weeks, 50%±90% of B and T cells expressedcommon, c-FLIP-regulated death pathway in lympho-
cytes (Kataoka et al., 1998). In agreement with this, we GFP in both GFP and FLIP mice, indicating that they
were derived from infected bone marrow precursors andhave found that retrovirus-mediated expression of dom-
inant-negative FADD blocked Fas killing equally in ma- still expressed retrovirus-encoded genes (Figure 2). In
agreement with this, Western blot analysis of the boneture B and T cells (L. V. P. and D. B., unpublished data).
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Figure 2. Normal Development of Lymphocytes in FLIP Mice
Lethally irradiated mice were reconstituted with syngeneic bone marrow cells that had been infected with a c-FLIP-expressing (FLIP) or control
(GFP) retrovirus in vitro. After 8 weeks, the percentage of lymphocytes in the bone marrow (A), thymus (B), and spleen (C) that expressed
GFP (histograms) was determined by staining and flow cytometry. To determine whether retrovirus-mediated expression of c-FLIP interfered
with lymphocyte development, the expression of specific surface markers (dot plots) was examined by gating on GFP positive cells. (D)
Expression of retrovirus-encoded c-FLIP by lymphocytes in vivo was confirmed by Western blot analysis using an antibody to the N-terminal
flag epitope.
marrow, thymus, and spleen of FLIP mice demonstrated Retrovirus-Mediated Expression of c-FLIP Does
Not Affect Lymphocyte Activation or Immunerobust expression of flag-tagged c-FLIP in these tissues
(Figure 2). Equal levels of GFP expression were also Responses to Foreign Antigens
To test the effect of c-FLIP expression on the activationfound in other bone marrow±derived cells, including
macrophages and dendritic cells (data not shown). of naive lymphocytes, mature B and T cells were isolated
from reconstituted mice by flow cytometric sorting andA role for death receptor signaling pathways in lym-
phocyte development and activation has been sug- stimulated in vitro with increasing concentrations of mi-
togenic antibodies. GFP and FLIP B cells activated withgested by recent experiments examining the in vivo role
of FADD, the molecule that is responsible for recruiting antibodies to IgM or CD40, and T cells activated with
antibodies to CD3 and CD28, showed similar prolifera-procaspase 8 to the cytoplasmic domain of Fas (Boldin
et al., 1995; Chinnaiyan et al., 1995). Mice in which this tion in these assays (Figure 3), indicating that retrovirus-
mediated expression of c-FLIP did not affect lympho-gene has been ablated or that express a dominant-
negative form of FADD show defects in B and T cell cyte activation. In agreement with our in vitro results,
activated lymphocytes derived from FLIP mice were re-development and in T cell activation (Newton et al., 1998;
Walsh et al., 1998; Zhang et al., 1998). Therefore, we sistant to Fas-mediated apoptosis (data not shown).
Lymphocyte apoptosis also plays a role in determiningexamined whether retroviral expression of c-FLIP af-
fected these processes. Contrary to the finding with the duration and magnitude of immune responses fol-
lowing infection or immunization, although the contribu-FADD, no significant differences were observed in lym-
phocyte maturation between GFP and FLIP mice or in tion of death receptors to this process is not clear (Van
Parijs and Abbas, 1998). To test whether constitutivethe distribution of mature B and T lymphocytes in GFP
positive (infected) and negative (noninfected) popula- expression of c-FLIP affected the immune response to
a foreign antigen, GFP and FLIP mice were immunizedtions in individual FLIP mice (Figure 2). This suggests
that FADD-dependent developmental signals may be with trinitrophenol-conjugated ovalbumin (TNP-OVA). B
and T cell responses were assessed 7 and 21 days afterindependent of caspase 8 activation through death re-
ceptors or that these signals can be provided in trans immunization by assaying anti-TNP antibody titers in
the serum and the response of lymph node T cells toin our reconstituted mice.
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Figure 4. Superantigen-Mediated Deletion of T Cells Is Defective in
FLIP Mice
GFP and FLIP mice (four per group) were treated with PBS (-) or SEB
(1). After 7 days, the percentage of Vb8 positive (SEB-responsive),
infected (1, GFP positive), and not infected (-, GFP negative) T
cells in the spleen was determined by flow cytometry. Each symbol
represents an individual mouse.
process can be mimicked by treating mice with a super-
antigen, which leads to the elimination of superantigen-
responsive T cells (White et al., 1989). We therefore
treated GFP and FLIP mice with the superantigen, staph-
ylococcus enterotoxin B (SEB), and followed the fate of
Vb8 positive (SEB-responsive) T cells in the spleen. As
shown in Figure 4, both infected and noninfected Vb8
positive T cells were deleted by SEB in GFP mice, while
only noninfected cells were eliminated in FLIP mice. In
these mice, GFP positive (infected) T cells were pro-
tected from SEB-mediated deletion, indicating that
c-FLIP blocks the elimination of mature T cells responding
to antigen in vivo.
Figure 3. Normal Lymphocyte Activation and Immune Responses Although less well defined, a role for death receptors
in FLIP Mice has been proposed in negative selection of thymocytes
(A) T and B cells were purified from GFP and FLIP mice by FACS (Amakawa et al., 1996). To test whether c-FLIP could
sorting and cultured in the presence of anti-CD3 and anti-CD28 (1 block this process, we generated c-FLIP mice that were
mg/ml) (T cells) or either anti-IgM (1 mg/ml) or anti-CD40 (1 mg/ml) of the C57BR strain. This strain of mouse expresses
(B cells). Proliferation was assessed after 96 hr using a colorimetric
an endogenous superantigen that eliminates Vb17a-assay. GFP and FLIP mice (two mice per group) were immunized
expressing T cells in the thymus (Kappler et al., 1987).with TNP-OVA and LPS, as an adjuvant.
We observed equivalent deletion of Vb17a positive thy-([B], top panel) After 7 (data not shown) or 21 days (shown), T cell
responses were measured by restimulating draining lymph node mocytes in GFP (% Vb17a/GFP positive thymocytes:
cells with OVA in vitro. Proliferation was assessed after 96 hr using immature [TCRlo] 2.6 6 0.6, mature [TCRhi] 0.1 6 0.2, n 5
a colorimetric assay. 5) and FLIP mice (% Vb17a/GFP positive thymocytes:
([B], bottom panel) B cell responses were tested by assaying serum
immature [TCRlo] 3.1 6 0.2, mature [TCRhi] 0.3 6 0.1,levels of anti-TNP antibodies by ELISA after the same time intervals
n 5 5), suggesting that retrovirus-mediated expression(results after 21 days shown). The titer of anti-TNP antibodies of the
of c-FLIP did not affect this process.IgG2a isotype (shown) as well as IgM or IgG1 isotypes (data not
shown) was determined by using developing antibodies with the
appropriate specificity. Retrovirus-Mediated Expression of c-FLIP Leads
to the Accumulation of Activated B Cells
and Autoimmune DiseaseOVA stimulation in vitro. GFP and FLIP mice showed
identical responses to immunization at both time points, The final set of experiments tested the effect of constitu-
tive c-FLIP expression on the maintenance of immuno-suggesting that c-FLIP expression did not affect this
process (Figure 3). logical tolerance. Control GFP (n 5 32) and FLIP (n 5
36) mice were allowed to age for 4±6 months following
bone marrow reconstitution, at which time we examinedRetrovirus-Mediated Expression of c-FLIP Blocks
Superantigen-Mediated Elimination of T Cells the cell numbers and GFP and c-FLIP expression levels
in lymphoid tissues. This time interval was chosen be-An important function of the Fas death receptor is to
eliminate mature B and T cells responding to self-anti- cause we had previously established that young Fas-
deficient (lpr) mice of the C57BL strain, which had beengens (Van Parijs and Abbas, 1998). Experimentally, this
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Figure 5. Accumulation of Activated B Cells
in FLIP Mice
The expression of retroviral genes (GFP) in
spleen cells from GFP and FLIP mice was
examined by flow cytometry 4±6 months after
reconstitution (histograms). The distribution
of T cells (Thy 1 positive cells) and B cells
(B220 positive cells) within the infected (GFP
positive) and not infected (GFP negative)
spleen populations, and the level of surface
IgM expressed by infected (GFP positive) and
not infected (GFP negative) B cells, was de-
termined by staining and flow cytometry (dot
plots).
irradiated and reconstituted with syngeneic lpr bone The GFP positive lymphocytes that accumulated in
FLIP mice included both T and B cells (Figure 5), al-marrow, required approximately 4 months to develop
disease symptoms (Figure 6; data not shown). Aged though most mice showed a preferential increase in the
latter (Figure 5; Table 1). The majority of GFPhi B cells,GFP mice still showed expression of retroviral gene
products by flow cytometry, although typically the per- but not T cells, showed signs of having been activated.
They were IgMlo as well as L-selectinlo, and a detectablecentage of cells expressing GFP in the bone marrow
and, particularly, the thymus, was reduced compared fraction of them expressed surface antibody of multiple
IgG isotypes (Figure 5; Table 1). The accumulation ofto mice that had been reconstituted 8 weeks prior to
analysis (Figures 2 and 5; data not shown). This was activated B cells in FLIP mice was dependent on c-FLIP
expression because GFP negative B cells in these micealso reflected in a decrease in the fraction of mature
lymphocytes, especially T cells, that expressed GFP in remained phenotypically naive (Figure 5; Table 1). The
frequency of FLIP mice that had increased numbers ofthe spleen and lymph nodes. FLIP mice showed a similar
reduction in the fraction of GFP positive cells in the GFPhi B cells (94%), and the fact that these cells ex-
pressed multiple isotypes of surface Ig, made it unlikelybone marrow, thymus, and peripheral lymphoid tissues.
However, they did have an increased percentage of that infected B cells accumulated as a consequence of
a transforming event. To confirm this, we examined thespleen and lymph node cells that expressed high levels
of GFP (Figure 5; Table 1). In a previous study, we have clonal relationship of these cells by analyzing the V(D)J
recombination products of sorted (GFPhi, B220 positive)shown that a linear relationship exists between the level
of GFP and test protein expressed by the retrovirus cells (Roman et al., 1997). These experiments demon-
strated that multiple cell lineages were present in thisconstruct in T cells, suggesting that these GFPhi cells
also express higher levels of c-FLIP (Van Parijs et al., population (data not shown).
To examine whether the accumulating B cells in FLIP1999). Furthermore, the number of cells found in the
peripheral lymphoid tissues of FLIP mice was typically mice were responding to self-antigens, we tested for
signs of B cell±dependent autoimmunity. A characteris-twice that of age-matched GFP mice (Table 1). There-
fore, retrovirus-mediated expression of c-FLIP disrupted tic of lpr mice and other autoimmune strains is that
they have elevated levels of serum immunoglobulin andlymphoid homeostasis and resulted in the accumulation
of mature lymphocytes expressing high levels of this autoantibodies and develop autoimmune disease (Co-
hen and Eisenberg, 1991). Therefore, we examinedmolecule.
Table 1. Spleen Cell Populations in GFP and FLIP Mice
Percent B220 Percent IgM Percent IgG2a Percent IgG1 Percent
Total Spleen Positive Positive Positive Positive L-Selectinhi
Cell Numbers Spleen Cells B Cells B Cells B Cells B Cells
GFP mice 41.8 6 9.4 GFP1 cells (infected) 60.9 6 8.0 95.0 6 1.4 0.7 6 0.3 0.4 6 0.2 71.3 6 1.5
(n 5 8)
FLIP mice 80.4 6 31.6 GFP1 cells (infected) 68.8 6 14.2 43.2 6 6.9 3.6 6 0.6 3.4 6 0.6 28.2 6 5.8
(n 5 10)
GFP2 cells (not infected) 60.0 6 5.8 92.4 6 2.1 0.5 6 0.1 0.6 6 0.1 74.7 6 5.5
GFP and surface expression of B220, Ig, or L-selectin on spleen cells from aged (4±6 months post reconstitution) GFP and FLIP mice was
determined by staining and flow cytometry.
RE
TR
AC
TE
D
Immunity
768
Figure 6. Autoimmunity in FLIP Mice
(A) Serum levels of antibodies specific to dsDNA in GFP (n 5 8) and FLIP (n 5 8) mice 4±6 months after reconstitution were determined by
ELISA. For comparison, anti-dsDNA titers were also assayed in wild-type or lpr bone marrow chimeras after the same time interval. Kidney
sections from GFP and FLIP mice stained with hematoxylin-eosin ([B], GFP mouse; [C], FLIP mouse) or an antibody to mouse IgG ([D], GFP
mouse; [E], FLIP mouse).
whether this was also the case in FLIP mice. Aged FLIP Conclusions
In this study, we have examined the expression of c-FLIPmice had high levels of anti-dsDNA autoantibodies (Fig-
ure 6) as well as elevated levels of serum IgG of all in naive and activated B and T cells and have tested
the notion that the reduced levels of c-FLIP in activatedisotypes (data not shown). Histological analysis of kid-
neys from these mice revealed extensive glomerular lymphocytes allow death receptor±mediated elimination
of autoreactive cells and prevent the development ofsclerosis and thickening of the mesangium and base-
ment membranes, with IgG deposition (Figure 6). These autoimmune reactions. In agreement with previous stud-
ies (Irmler et al., 1997; Kataoka et al., 1998; Refaeli etfindings are characteristic of antibody or immune
complex±mediated glomerulonephritis. Thus, retrovirus- al., 1998), we have found that c-FLIP functions as a
specific inhibitor of death receptor±mediated apoptosismediated expression of c-FLIP resulted in the accumula-
tion of autoreactive B cells and autoimmune tissue in primary B and T cells. Importantly, the loss of c-FLIP
expression seen during lymphocyte activation in vitrodamage.
Interestingly, our aged FLIP mice did not show a large correlates with an increased sensitivity to death recep-
tor±mediated killing (Irmler et al., 1997; Refaeli et al.,increase in activated T cells or the B220 positive T cells
that are characteristic of lpr and gld mice (Cohen and 1998). In vivo, overexpression of c-FLIP is sufficient to
break self-tolerance, presumably by preventing theEisenberg, 1991). A trivial reason for this might be that
the reduced retroviral gene expression seen in the T elimination of lymphocytes responding to self-antigens.
This suggests that deregulated c-FLIP expression mightcells of most (n 5 27) aged mice no longer protected
self-reactive T cells from death receptor±mediated elimi- be involved in certain autoimmune pathologies. In-
appropriate gain of FLIP expression could occur as anation. However, in vitro activated GFP positive T cells
from all aged FLIP mice were resistant to AICD (data result of virus infection or abnormal lymphocyte activa-
tion. Alternatively, loss of FLIP expression would rendernot shown). Furthermore, we saw no increase in the
number of activated T cells in nine aged FLIP mice that cells more sensitive to death receptor±mediated apo-
ptosis and might promote immune-mediated tissueexpressed GFP in a high percentage (.50%) of these
cells (data not shown). Alternatively, it is possible that damage.
Activated lymphocytes do not always become sensi-inhibiting caspase activation by itself does not result in
the accumulation of T cells and that defects in other tive to death receptor±mediated apoptosis. T cells stim-
ulated in the absence of IL-2 and B cells activated insignaling pathways are responsible for the increased
numbers of these cells seen in Fas-deficient mice. Con- the presence of a B cell receptor signal remain resistant
to Fas-mediated apoptosis (Rothstein et al., 1995; Re-sistent with this hypothesis, transgenic mice that ex-
press the viral caspase inhibitor, CrmA, in T cells show faeli et al., 1998; L. V. P., unpublished data). These cells
also maintain high levels of c-FLIP expression (Refaelidefective Fas killing but do not have increased numbers
of activated cells or develop autoimmunity (Smith et al., et al., 1998; Wang et al., 2000; L. V. P., unpublished
data). In vivo, we have found that adjuvants promote1996).
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were assayed by determining serum anti-TNP titers (Sethna et al.,the expression of c-FLIP transcripts in activated T cells
1994), and T cell responses were measured by restimulating cellsresponding to superantigens (L. V. P. and D. B., unpub-
from draining lymph nodes in vitro with OVA (Sethna et al., 1994)lished data). Therefore, one physiological role of c-FLIP
and assaying proliferation after 72 hr using a vital dye (CellTiter
may be to function as a ªmolecular switchº that deter- proliferation assay, Promega).
mines whether an immune response is terminated or In T cell deletion experiments, mice were harvested 7 or 8 days
after they had been treated with 50 mg SEB (Sigma). Spleen cellsallowed to develop. The results presented here indicate
were stained with antibodies to Vb8 and CD4 (PharMingen) to evalu-that the reduction of c-FLIP levels following the activa-
ate the percentage of SEB-responsive (Vb8) CD41 T cells present.tion of autoreactive lymphocytes serves to sensitize
them for death receptor±mediated elimination. In con-
Autoantibodies and Kidney Pathology
trast, lymphocytes responding to microbes and viruses Serum immunoglobulin levels were determined by ELISA as de-
are likely to maintain the expression of c-FLIP or related scribed in Sethna et al. (1994) and anti-dsDNA levels as described
molecules to protect from death receptor±mediated kill- in Kabra et al. (1999). Kidneys from GFP and FLIP mice were fixed
with 10% paraformaldehyde and embedded in paraffin. Sections (4ing, thus allowing them to mount a protective immune
mm) were stained with hematoxylin-eosin and evaluated for abnor-response. The role of FLIPs in the generation of immuno-
malities in glomerular architecture or with a Cy3-conjugated anti-logical memory remains to be tested. The retrovirus-
body to mouse IgG as described in Fukuyama et al. (1998) to detect
based approach we have employed here provides an immunecomplex deposition.
efficient means to further characterize the normal and
pathological roles of FLIPs and other regulators of cellu- Western Blot Analysis
The levels of retrovirally expressed FLIP protein were determinedlar function.
by Western blot analysis. Cells were obtained from thymus, lymph
nodes, or spleens and washed twice in chilled Dulbecco's PBSExperimental Procedures
(Gibco/BRL). Cells were lysed in 0.1% NP-40 containing lysis buffer,
as previously described (Refaeli et al, 1998). Lysates were run onMice and Bone Marrow Reconstitution Experiments
12% SDS-PAGE. Blots were probed with an anti-FLAG antibodyC57BL/6 and C57/BR mice were obtained from the Jackson Labora-
(M-2, Kodak-IBI), followed by a rabbit anti-mouse HRP-conjugatedtory (Bar Harbor, ME). Bone marrow cells were harvested from the
antibody (Santa Cruz Biotechnology). Western blots were developedtibia and femur of C57BL or C57BR mice 5 days after they received
using an ECL kit (Amersham) and exposed to XAR film (Kodak).an intraperitoneal injection of 5 mg 5-fluorouracil (Sigma) in Dulbec-
co's PBS (Gibco/BRL). These cells were then cultured for 4 days at
Acknowledgmentsa density of 2 3 106 cells/ml with 20 ng/ml rmIL-3, 50 ng/ml rmIL-6,
and rm50 ng/ml SCF (all obtained from R&D Systems) in DMEM
We are grateful to J. Tschopp (University of Lausanne) for his giftcontaining 10% FCS. After 48 and 72 hr, the bone marrow cells
of the cDNA for flag-tagged c-FLIP, N. Hacohen (Whitehead Insti-were spin infected with control and FLIP-expressing retroviruses
tute) for his gift of DO.11.10 mice, N. Rozengurt (UCLA) for per-that were generated as described (Van Parijs et al., 1999). After spin
forming the histological analysis of GFP and FLIP mice, and Rochelleinfections, the retroviral supernatant was removed and replaced
Diamond (Caltech) for performing the cell sorting. L. V. P. is a recipi-with growth media containing cytokines. Recipient mice received a
ent of an Arthritis Foundation Postdoctoral Fellowship, and Y. R. istotal of 1,200 rads whole body radiation in two doses (800 and 400
a recipient of a predoctoral fellowship from the Howard Hughesrads) 3 hr apart and were then injected with 2 to 5 3 105 infected
Medical Institute. Supported by NCI CA54162 to D. B. and NIHbone marrow cells. Irradiated mice were maintained on trimetha-
AI42100 to A. K. A.prim-sulphamethoxazole in sterile cages for 4 to 6 weeks to prevent
opportunistic infections.
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